Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04034927 |
|---|---|
| Brief Title: | Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer |
| First Submitted : | July 25, 2019 |
| First Submitted that Met QC Criteria : | July 25, 2019 |
| First Posted : | July 29, 2019 |
| Last Update Submitted that Met QC Criteria : | December 17, 2020 |
| Last Update Posted : | December 19, 2020 |